Metropolis Healthcare Ltd Share Price Today - Metropolis Healthcare Ltd Stock Price Live NSE/BSE

Metropolis Healthcare Ltd

NSE: METROPOLIS BSE: 542650

₹1947.80

(-1.99%)

Sat, 14 Feb 2026, 07:46 am

MTF 5xInvest in Metropolis Healthcare Ltd with 5x Leverage Buy with MTF

Market Cap102.86B

PE Ratio60.20

Dividend0.20

Health Services

Medical/Nursing Services

24.5K

Metropolis Healthcare Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
10091.42
Net Profit
145.51
P/B
6.12
Sector P/E
57.52
P/E
55.83
EV/EBITDA
25.51
Debt/Equity (Industry)
0.19
Interest Cover (Industry)
12.58
ROCE (Industry)
18.36
RONW (Industry)
15.35
ROE
11.99
ROCE
14.96
Debt/Equity
0.17
EPS (TTM)
33.75
Dividend Yield
0
Book Value
276.37
Interest Cover
8.99

Analysis

all

Pros

Dividends paid are well covered by earnings (3.2x coverage).
Dividends after 3 years are expected to be covered by earnings (1.8x coverage).
Metropolis Healthcare's earnings are expected to grow significantly at over 20% yearly.
Metropolis Healthcare's earnings growth is expected to exceed the India market average.
Metropolis Healthcare's earnings growth is expected to exceed the low risk savings rate of 7.2%.

Cons

Metropolis Healthcare only just started paying a dividend, it is too early to tell if payments are increasing.
It is too early to tell whether Metropolis Healthcare has stable dividend payments.
Metropolis Healthcare's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
Metropolis Healthcare's dividend is below the markets top 25% of dividend payers in India (3.08%).
Cash flow for Metropolis Healthcare is expected to increase but not above the 50% threshold in 2 years time.

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	48.88	48.89	48.89	48.90	49.40
FII	11.69	12.52	12.83	15.29	16.73
DII	34.73	33.10	32.40	30.30	30.00
Public	4.71	5.49	5.88	5.52	3.87
Government	0	0	0	0	0

Technical Analysis

RSI

52.68

MACD

20.69

50 DMA

1915.97

200 DMA

1915.54

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	2522.50	2207.60	2040.30	1892.70	1725.40	1577.80	1262.90
Fibonacci	2207.60	2087.31	2012.99	1892.70	1772.41	1698.09	1577.80
Camarilla	1959.60	1930.73	1901.87	1892.70	1844.13	1815.27	1786.40

Pivots Level: Classic

+629.80

2522.50

+314.90

2207.60

+147.60

2040.30

1892.70

Pivot Point

LTP: 1947.80

-167.30

1725.40

-314.90

1577.80

-629.80

1262.90

Moving Average

SMAEMA

Period

Value

10-EMA
1958.05
20-EMA
1936.95
30-EMA
1929.52
50-EMA
1929.25
100-EMA
1935.49
200-EMA
1924.94

Announcement Date	Purpose	Action	Ex Date
04 Feb 2026	board-meetings	Quarterly Results
04 Nov 2025	dividend	₹4.00 Dividend /Share	11 Nov 2025
04 Nov 2025	board-meetings	Quarterly Results, Interim Dividend
22 Jul 2025	agm
31 Jul 2024	agm
04 Nov 2023	dividend	₹4.00 Dividend /Share	17 Nov 2023
21 Jul 2023	agm
10 Feb 2023	dividend	₹8.00 Dividend /Share	23 Feb 2023
20 Jul 2022	agm
11 Feb 2022	dividend	₹8.00 Dividend /Share	22 Feb 2022

Metropolis Healthcare Ltd

Apollo Hospitals Enterprise Ltd

Max Healthcare Institute Ltd

Aster DM Healthcare Ltd

Narayana Hrudayalaya Ltd

Fortis Healthcare Ltd

Metropolis Healthcare Ltd About

Metropolis Healthcare is engaged in the business of providing pathology and related healthcare services.

Industry

Healthcare

Founded

2000

Headquarters

CEO

Ameera Sushil Shah

Employees

Contact

Website

http://www.metropolisindia.com

investor.relations@metropolisindia.com

Phone

91-22-62582810

Location

250 D Udyog Bhavan, Worli, Mumbai, Maharashtra, 400030

Year	History
2017	Metropolis Healthcare acquired Sanjeevani Pathology Laboratory in Rajkot.
2018	Metropolis Healthcare executed a Public-Private partnership agreement with the National AIDS Control Organisation, Government of India. Metropolis Healthcare implemented the Scheme of Amalgamation 2018. Metropolis Healthcare incorporated a subsidiary in Tanzania. Metropolis Healthcare was awarded for 'Best in Health and Fitness' in the Digital Campaign Awards by LH Insights. Metropolis Healthcare was awarded for 'Excellence in Customer Service & Delivery' by Biotrains. Metropolis Healthcare received a special jury mention for 'Service Excellence (Diagnostic Centre)' by FICCI at the Healthcare Excellence Awards.
2020	Metropolis Healthcare won the India CSR award for the 'Too Shy To Ask' App. Metropolis Healthcare was awarded India Diagnostic Service Provider Company of the year 2020.
2021	Metropolis Healthcare completed the acquisition of Hitech Diagnostic Centre. Metropolis Healthcare's Board of Directors approved the acquisition of Dr. Ganesan's Hitech Diagnostic Centre.
2024	Metropolis Healthcare Limited completed the acquisition of Metropolis Foundation. Metropolis Healthcare Limited acquired a 100% stake in Core Diagnostics Private Limited.

Client Name	Order Side	QTY	Avg Price	Date
CORE DIAGNOSTICS (MAURITIUS) PRIVATE LIMITED	Sell	292457	1905.11	04 Dec 2025

Metropolis Healthcare Ltd News

Metropolis Healthcare Approves 3:1 Bonus Issue

Metropolis Healthcare has approved the issuance of bonus equity shares at a ratio of 3:1, providing shareholders with three additional shares for every share held.

04 Feb 2026

co actions results

Metropolis Healthcare Q3FY26 Earnings Call on Feb 5

Metropolis Healthcare announces earnings conference call scheduled for February 5, 2026 at 09:00 AM IST to discuss Q3FY26 financial results for quarter ended December 31, 2025, organized by ICICI Securities.

30 Jan 2026

co actions results

Metropolis Healthcare Allots 9,960 Equity Shares

Metropolis Healthcare Limited allotted 9,960 equity shares at ₹2 per share under its RSU Plan 2020, with 50% shares subject to one-year lock-in period starting January 13, 2026.

13 Jan 2026

co actions results

Metropolis to expand genomics tests to 500 in 2 years

Metropolis Healthcare launches Centre for Genomics, plans to expand test menu from 220 to 500 tests over next two years. Company targets 13-15% organic growth in FY26-27 with specialty tests contributing 38% of revenue.

13 Jan 2026

stocks

Metropolis Healthcare launches genomics centre

Metropolis Healthcare launches Centre of Genomics with CAP-accredited labs in Mumbai and Delhi NCR, plans to expand genomic portfolio to 500+ tests over 2-3 years from current 220+ validated assays.

13 Jan 2026

stocks

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800